The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats (Q30497495)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats |
scientific article |
Statements
1 reference
The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats (English)
1 reference
Joshua S Beckmann
1 reference
Kiran B Siripurapu
1 reference
Justin R Nickell
1 reference
David B Horton
1 reference
Emily D Denehy
1 reference
Ashish Vartak
1 reference
Peter A Crooks
1 reference
Linda P Dwoskin
1 reference
Michael T Bardo
1 reference
30 August 2010
1 reference
1 reference
335
1 reference
3
1 reference
841-851
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference